2024-05-10  10:00:00 PM Chg. +0.7200 Volume Bid10:10:27 PM Ask10:10:27 PM Market Capitalization Dividend Y. P/E Ratio
107.1000USD +0.68% 291,915
Turnover: 17.69 mill.
42.8200Bid Size: 200 171.2400Ask Size: 200 2.61 bill.USD - -

Business description

About ICU Medical, Inc. (Nasdaq:ICUI) develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. ICU Medical's products improve patient outcomes by helping prevent bloodstream infections and protecting healthcare workers from exposure to infectious diseases or hazardous drugs. The company's complete product line includes custom IV systems, closed delivery systems for hazardous drugs, needlefree IV connectors, catheters and cardiac monitoring systems. ICU Medical is headquartered in San Clemente, California.
 

Management board & Supervisory board

CEO
Vivek Jain
Management board
Brian Bonnell, Christian Voigtlander, Dan Woolson, Virginia Sanzone
Supervisory board
Vivek Jain, David C. Greenberg, David Hoffmeister, Donald Abbey, Elisha Finney, George A. Lopez, M.D., Laurie Hernandez, Robert S. Swinney, M.D.
 

Company data

Name: ICU Medical Inc.
Address: 951 Calle Amanecer,San Clemente, California 92763, USA
Phone: +1-949-366-2183
Fax: +1-949-366-8368
E-mail: -
Internet: www.icumed.com/
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12-31
Free Float: 58.80%
IPO date: -

Investor relations

Name: John Mills
IR phone: +1-949-366-4238
IR Fax: -
IR e-mail: ir@icumed.com

Main Shareholders

Freefloat
 
58.80%
T. Rowe Price Associates, Inc.
 
12.50%
Janus Henderson Group
 
12.40%
The Vanguard Group, Inc.
 
8.50%
BlackRock Inc.
 
7.80%